|This entire article is available in PDF format to paid subscribers (certain restrictions apply).
If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Effects of Stimulant Medication on Neuropsychological Functioning in Young Adults With Attention-Deficit/Hyperactivity Disorder
Joseph Biederman, M.D.; Larry J. Seidman, Ph.D.; Carter R. Petty, M.A.; Ronna Fried, Ed.D.; Alysa E. Doyle, Ph.D.; Daniel R. Cohen, B.A.; Deborah C. Kenealy, B.A.; and Stephen V. Faraone, Ph.D.
Objective: The main goal of this study was to evaluate the impact of stimulant medication on executive function deficits in a group of adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD; DSM-III-R criteria).
Method: Male and female subjects aged 15 to 25 years were divided into 3 groups: subjects with ADHD treated with stimulants who took their medication at the time of testing (ADHD active stimulant treatment: N=26), subjects with ADHD who had not taken stimulant medication in the past month (ADHD no stimulant treatment: N=94), and non-ADHD control subjects (controls: N=133). The neuropsychological battery assessed domains of cognitive functioning known to be relevant in ADHD, including tests of executive functions and learning and memory. Data were collected from July 1998 to April 2003.
Results: The ADHD no stimulant treatment group had significantly lower aggregate scores compared with the controls for the total aggregate, working memory, interference control, processing speed, sustained attention, and verbal learning domains (all p<.001). The ADHD active stimulant treatment group had significantly poorer scores on the total aggregate (p=.002), interference control (p<.001), and processing speed (p=.003) domains compared with the controls. The ADHD active stimulant treatment subjects scored significantly higher on the domains of sustained attention (p=.04) and verbal learning (p=.03) compared with the ADHD no stimulant treatment subjects.
Conclusions: Our study showed that subjects with ADHD who took stimulant medication had higher neuropsychological measures of attention compared with subjects with ADHD who did not take stimulant medication, but differences were not found for other measures of executive function.
(J Clin Psychiatry 2008;69:1150-1156. Online Ahead of Print May 27, 2008.)
Received June 26, 2007; accepted Oct. 15, 2007. From the Pediatric Psychopharmacology Program of the Psychiatry Department, Massachusetts General Hospital, Boston (Drs. Biederman, Seidman, Fried, and Doyle; Messrs. Petty and Cohen; and Ms. Kenealy), and the Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, N.Y. (Dr. Faraone).
This work was financially supported, in part, by a grant numbered 5RO1 HD-36317-07 from the United States Public Health Service (National Institute of Child Health and Human Development), Rockville, Md. (Dr. Biederman). Support also came, in part, from the Neal-Kimmerly Fund for the Study of Cognition, Boston, Mass. Dr. Biederman had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Financial disclosure appears at the end of the article.
Corresponding author and reprints: Joseph Biederman, M.D., Massachusetts General Hospital, Pediatric Psychopharmacology Unit, 55 Fruit St., Warren 705, Boston, MA 02114 (e-mail: email@example.com).